Editas Medicine EDIT 深 沪
已收盘 08-21 16:00:00 美东时间
3.11
+0.170
+5.78%
华盛通- 最 高3.245
- 今 开2.98
- 成交量 211.64万股
- 最 低 2.95
- 昨 收 2.94
- 总市值 4.78亿
- 52周最高 4.5372
- 市盈率 静 --
- 换手率 1.38%
- 52周最低 1.66
- 委 比 -20.64%
- 总股本 1.54亿
- 历史最高 99.95
- 量 比 0.54
- 振 幅 10.03%
- 历史最低 0.9101
- 每 手 1
- 风险率 0.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were mixed, with the Dow Jones index gaining over 200 points on Wednesday. Shares of Estee Lauder Companies Inc (NYSE:EL) rose sharply after the company reported better-than-expected fourth-quarter financial results and issued its FY27 sales guidance with its midpoint above estimates. Ad...
08-19 22:08
Editas Medicine Q2 EPS $(0.15) Beats $(0.27) Estimate, Sales $11.900M Beat $2.800M Estimate
Editas Medicine (NASDAQ:EDIT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.27) by 44.44 percent. This is a 76.19 percent increase over losses of $(0.63) per share from the same period last year. The company reported quarterly sales of $11.900 millio...
08-06 04:37
Rivian Automotive, Tenax Therapeutics, Robinhood And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining around 450 points on Thursday. Shares of Rivian Automotive Inc (NASDAQ:RIVN) rose sharply on Thursday after the company released second-quarter production and delivery figures and raised full year delivery forecast. The company produced 12,61...
07-02 22:24
高脂血症，基因编辑药企：融资1.25亿美元
本文不构成任何投资意见和建议，以官方/公司公告为准；本文仅作医疗健康相关药物介绍，非治疗方案推荐（若涉及），不代表平台立场。任何文章转载需得到授权。 药融圈数据...
06-07 10:30
美股牛股 | VTIX飙升46%，获美国空军SBIR项目资金支持；360数科大涨25%
VTIX飙升46%，获美国空军SBIR项目资金支持；APPS大涨38%，财报强劲，美银称其增长前景清晰；360数科大涨25%，用户规模稳步扩容，信贷投放有所收缩>>
05-28 19:22
Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 300 points with gains from Abercrombie & Fitch, Digital Turbine, Dycom Industries, Qfin Holdings, Editas Medicine, and others.
05-27 22:51
Editas Medicine Prices $125M Public Offering Of 55.6M Shares And Warrants At $2.25 Each
Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced the pricing of an underwritten public offering of 55,555,556 shares of its
05-26 21:08
Editas Medicine stock dips on proposed equity offering
Editas Medicine (EDIT) shares fell nearly -12% premarket on Tuesday after the gene editing company launched an underwritten public offering of its common stock (or pre-funded warrants to purchase shar...
05-26 18:53
Editas Medicine Launches Public Stock Offering to Raise Capital
Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, today announced that it has commenced an underwritten public offering of its common stock
05-26 18:19
